![]() Oncomatryx Oncomatryx Biopharma is a biopharmaceutical company focused on the tumor microenvironment. | ![]() Aravive Aravive is a clinical-stage biotechnology company developing therapies for solid tumors and hematologic malignancies. | Diatech Pharmacogenetics Diatech Pharmacogenetics is a provider of molecular diagnostic tools for precision medicine. | ![]() Oxford Cancer Biomarkers Oxford Cancer Biomarkers (OCB) is a company that develops and commercializes biomarker tests. | ||
Founding Date | Founding Date 2009 | Founding Date 2008 | Founding Date 1997 | Founding Date 1994 | Founding Date 2012 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations HQ | Locations Houston, US HQ | Locations Lund, SE HQ | Locations Jesi, IT HQ | Locations Kilmacolm, GB HQ |
Employees | Employees 274% increase | Employees 23 | Employees 118 | Employees 751% increase | Employees 713% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 2.9 m | Valuation ($) 285.9 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $9.1m (FY, 2022) | Revenue (est.) kr226.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($76.3m) (FY, 2022) | Net income (kr332.9m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 4.9m (over 10 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 1.9m (almost 11 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 4.9m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 1.9m | Total funding raised N/A |

Aravive is a clinical-stage biotechnology company developing therapies for solid tumors and hematologic malignancies.
View company
BioInvent focuses on the discovery and development of antibody-based drugs against cancer.
View companyDiatech Pharmacogenetics is a provider of molecular diagnostic tools for precision medicine.
View company
Oxford Cancer Biomarkers (OCB) is a company that develops and commercializes biomarker tests.
View company